Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors.

× No keyword cloud information.

22 in total

Review 1. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors: N J Sarlis
Journal: Rev Endocr Metab Disord Date: 2000-04 Impact factor: 6.514

2. Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s).

Authors: Dongju Kim; Jin-Woo Park
Journal: J Korean Surg Soc Date: 2013-06-26

Review 3. Occupation and thyroid cancer.

Authors: Briseis Aschebrook-Kilfoy; Mary H Ward; Curt T Della Valle; Melissa C Friesen
Journal: Occup Environ Med Date: 2014-03-06 Impact factor: 4.402

4. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

Authors: K S Banu; P Govindarajulu; M M Aruldhas
Journal: Endocr Pathol Date: 2001 Impact factor: 3.943

5. Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?

Authors: C T Bahadir; G C Ecemis; H Atmaca
Journal: J Endocrinol Invest Date: 2018-03-14 Impact factor: 4.256

6. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.

Authors: Jacqueline Jonklaas; Hala Nsouli-Maktabi; Steven J Soldin
Journal: Thyroid Date: 2008-09 Impact factor: 6.568

Review 7. [Surgical resection of the thyroid and parathyroid glands].

Authors: U Woenckhaus; R Büttner; L C Bollheimer
Journal: Internist (Berl) Date: 2007-06 Impact factor: 0.743

8. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.

Authors: Megan Rist Haymart; Daniel John Repplinger; Glen E Leverson; Diane F Elson; Rebecca S Sippel; Juan Carlos Jaume; Herbert Chen
Journal: J Clin Endocrinol Metab Date: 2007-12-26 Impact factor: 5.958

9. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.

Authors: G Costante; U Crocetti; E Schifino; O Ludovico; C Capula; M Nicotera; F Arturi; S Filetti
Journal: J Endocrinol Invest Date: 2004-01 Impact factor: 4.256

10. Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: a retrospective study.

Authors: M Alba; D Fintini; R M Lovicu; R M Paragliola; G Papi; C A Rota; A Pontecorvi; S M Corsello
Journal: J Endocrinol Invest Date: 2009-04 Impact factor: 4.256